• 1456 Citations
  • 11 h-Index
20022018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Theodore Samuel Johnson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hemophagocytic Lymphohistiocytosis Medicine & Life Sciences
Antigen-Presenting Cells Medicine & Life Sciences
Neoplasm Antigens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

1 Citation (Scopus)

Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Meier, E. R., Johnson, T. S., Pinkney, K., Velez, M. C., Kamani, N. & Odame, I., Sep 1 2018, In : Pediatric Blood and Cancer. 65, 9, e27105.

Research output: Contribution to journalReview article

Hematopoietic Stem Cell Transplantation
Sickle Cell Anemia
Hematopoietic Stem Cells
Transplants
Siblings
24 Citations (Scopus)

Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors

Sharma, M. D., Rodriguez, P. C., Koehn, B. H., Baban, B., Cui, Y., Guo, G., Shimoda, M., Pacholczyk, R. W., Shi, H., Lee, E. J., Xu, H., Johnson, T. S., He, Y., Mergoub, T., Venable, C., Bronte, V., Wolchok, J. D., Blazar, B. R. & Munn, D. H., Jan 16 2018, In : Immunity. 48, 1, p. 91-106.e6

Research output: Contribution to journalArticle

Antigen-Presenting Cells
Myeloid Cells
Immunotherapy
Cell Differentiation
Cross-Priming
11 Citations (Scopus)

Treg Destabilization and reprogramming: Implications for cancer immunotherapy

Munn, D. H., Sharma, M. D. & Johnson, T. S., Sep 15 2018, In : Cancer Research. 78, 18, p. 5191-5199 9 p.

Research output: Contribution to journalReview article

Immunotherapy
Neoplasms
PTEN Phosphohydrolase
Cross-Priming
Indoleamine-Pyrrole 2,3,-Dioxygenase
8 Citations (Scopus)

Chemo-immunotherapy: Role of indoleamine 2,3-dioxygenase in defining immunogenic versus tolerogenic cell death in the tumor microenvironment

Johnson, T. S., McGaha, T. L. & Munn, D. H., Jan 1 2017, Advances in Experimental Medicine and Biology. Springer New York LLC, p. 91-104 14 p. (Advances in Experimental Medicine and Biology; vol. 1036).

Research output: Chapter in Book/Report/Conference proceedingChapter

Indoleamine-Pyrrole 2,3,-Dioxygenase
Tumor Microenvironment
Cell death
Chemotherapy
Immunotherapy
6 Citations (Scopus)

Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program

Badawy, S. M., Black, V., Meier, E. R., Myers, K. C., Pinkney, K., Hastings, C., Hilden, J. M., Zweidler-McKay, P., Stork, L. C., Johnson, T. S. & Vaiselbuh, S. R., Mar 1 2017, In : Pediatric Blood and Cancer. 64, 3, e26252.

Research output: Contribution to journalArticle

Mentors
Hematology
Pediatrics
Program Evaluation
Postal Service